CARLING, WILLIAM R.,MARTOS, JOSE L.,KANGASMETSA, JUSSI J.,WANG, JENNY W.,WOODWARD, DAVID F.
申请号:
CA2862266
公开号:
CA2862266C
申请日:
2012.12.21
申请国别(地区):
CA
年份:
2016
代理人:
摘要:
The present invention provides a compound, that is wherein Y, W, Z, R1, R2, R4, R5 and R6 are as defined in the specification. The compounds may be administered to treat DP, FP, EP1, TP and/or EP4 receptor-mediated diseases or conditions.